Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Noriaki Yorioka"'
Autor:
Yusuke Suzuki, Soichi Sakai, Takao Saito, Shoichi Fujimoto, Hideki Kimura, Yukio Yuzawa, Tetsuya Babazono, Hitoshi Yokoyama, Kazuhiko Tsuruya, Noriaki Yorioka, Masatoshi Mune, Shunya Uchida, Susumu Yukawa, Yoshiki Nishizawa, Hiroaki Oda, Tsutomu Hirano, Shoichi Maruyama, Hirokazu Honda, Satoshi Sugiyama, Eri Muso, Motoshi Hattori, Takashi Wada, Yasuhiko Iino, Osamu Ito, Kiyoshi Mori, Hiroshi Sato, Tatsuo Tsukamoto, Tetsuo Shoji, Tsuyoshi Watanabe, Akira Nishiyama, Youske Ogura, Reiko Inagi
Publikováno v:
Therapeutic Apheresis and Dialysis. 26:220-228
Many reports have shown the therapeutic efficacy of LDL apheresis (LDL-A) in drug-resistant nephrotic syndrome (NS) for improvement of heavy proteinuria and severely impaired renal function. To obtain comprehensive results in a large number of cases,
Autor:
Satoru Ogahara, Koichi Matsumoto, Akio Koyama, Enyu Imai, Hiroshi Sato, Tetsuya Mitarai, Yasuhiko Tomino, Yoshie Sasatomi, Shiro Ueda, Shoichi Maruyama, Hitoshi Yokoyama, Masayuki Iwano, Noriaki Yorioka, Masaomi Nangaku, Seiichi Matsuo, Takao Saito, Ashio Yoshimura, Yasufumi Kataoka, Shinichi Nishi
Publikováno v:
Clinical and Experimental Nephrology
Background We designed a prospective and randomized trial of mizoribine (MZR) therapy combined with prednisolone (PSL) for idiopathic membranous nephropathy (IMN) with steroid-resistant nephrotic syndrome (SRNS). Methods Patients with IMN were divide
Autor:
Yukio Yuzawa, Satoru Ogahara, Seiichi Matsuo, Satoshi Sugiyama, Tsutomu Hirano, Takashi Wada, Yasuhiko Iino, Tetsuo Shoji, Masatoshi Mune, Noriaki Yorioka, Soichi Sakai, Susumu Yukawa, Enyu Imai, Tsukasa Takemura, Yousuke Ogura, Hitoshi Yokoyama, Yoshiki Nishizawa, Takao Saito, Shunya Uchida, Hiroshi Sato, Tsuyoshi Watanabe, Kenjiro Kimura, Eri Muso, Motoshi Hattori
Publikováno v:
Nephron Extra, Vol 5, Iss 2, Pp 58-66 (2015)
Nephron Extra
Nephron Extra
Background/Aims: LDL apheresis (LDL-A) is used for drug-resistant nephrotic syndrome (NS) as an alternative therapy to induce remission by improvement of hyperlipidemia. Several clinical studies have suggested the efficacy of LDL-A for refractory NS,
Autor:
Junko Tanaka, Masayuki Ohisa, Takako Asao, Tomoyuki Akita, Junko Matsuo, Shinichiro Tsuchiya, Keiko Katayama, Noriaki Yorioka
Publikováno v:
Journal of Medical Virology
The prevalence of hepatitis C virus (HCV) infection is high among patients receiving chronic hemodialysis. To clarify the risk ratio of HCV infection with respect to mortality and prognosis in chronic hemodialysis patients, a retrospective longitudin
Publikováno v:
Journal of Artificial Organs. 18:251-256
In addition to the well-known traditional risk factors, uremia-related so-called novel risk factors and medications appear to affect coronary artery calcification in hemodialysis patients. This study was performed to evaluate coronary artery calcific
Publikováno v:
Health. :729-740
We developed a disease management program and service framework to enhance the self-management skills of patients with chronic diseases for the first time in Japan. In this study, we analyzed the efficacy of this program. A single-group pre-test and
Autor:
Shigehiro Doi, Akira Shimamoto, Nobuoki Kohno, Ayumu Nakashima, Shuma Hirashio, Noriaki Yorioka, Hidetoshi Tahara, Eriko Aoki, Kumiko Anno, Takao Masaki
Publikováno v:
Clinical Journal of the American Society of Nephrology. 9:2117-2122
Background and objectives Telomeric G-tails play a pivotal role in maintaining the intramolecular loop structure of telomeres. Previous in vitro studies have suggested that the erosion of telomeric G-tails triggers cellular senescence, leading to org
Autor:
Yoshihiro Tsujimoto, Yuzo Watanabe, Shinichiro Ueda, Masafumi Fukagawa, Akira Fujimori, Takashi Shigematsu, Ikuto Masakane, Toshitsugu Sugimoto, Mitsushige Nishikawa, Tetsuya Hashimoto, Tetsuo Shoji, Minoru Yoshiyama, Hideki Kawanishi, Hideki Hirakata, Masaaki Inaba, Hiroki Hase, Kazumichi Ohta, Koji Mitsuiki, Takayasu Ohtake, Yuji Ikari, Jun Minakuchi, Yoshiharu Tsubakihara, Kazuhiko Tsuruya, Noriaki Yorioka, Masashi Suzuki, Noritomo Itami, Mikio Okamura, Eiji Ishimura, Toshitaka Kakuta, Kenji Tanaka, Hideki Tahara, Takashi Mizuguchi, Ryoichi Ando, Shigeo Negi, Yoshihiro Tominaga, Tatsuo Hosoya, Senji Okuno, Tatsuya Nakatani, Yoshiaki Takemoto, Kiyoshi Maekawa, Tomoyuki Yamakawa, Kunitoshi Iseki, Daijo Inaguma, Masanori Emoto, Toru Inoue, Keitaro Yokoyama, Yoshitaka Isaka, Mitsuru Fukui, Chiharu Ito, Shozo Yano, Hirokazu Honda, Toyoaki Murohara, Junko Kumagai, Shuzo Kobayashi, Toru Kawai, Tetsuya Ogawa, Yoshiki Nishizawa, Hisako Fujii, Satoshi Morimoto, Shinichi Nishi, Kunihiro Yamagata
Publikováno v:
JAMA. 320:2325
Importance Patients with chronic kidney disease have impaired vitamin D activation and elevated cardiovascular risk. Observational studies in patients treated with hemodialysis showed that the use of active vitamin D sterols was associated with lower
Autor:
Shigehiro Doi, Yukio Yokoyama, Nobuoki Kohno, Toshinori Ueno, Takeshi Kawamoto, Noriaki Yorioka, Yukihito Higashi, Takao Masaki, Kiyomasa Honda, Yukio Kato, Ayumu Nakashima, Toshiki Doi
Publikováno v:
Kidney International
Mesenchymal stem cells (MSCs) are multipotent adult stem cells that have regenerative capability and exert paracrine actions on damaged tissues. Since peritoneal fibrosis is a serious complication of peritoneal dialysis, we tested whether MSCs suppre
Autor:
Masao Kim, Mark R. Marshall, Masaaki Nakayama, Noriaki Yorioka, Teruhiko Maeba, Hidemune Naito, Shigeko Hara, Takashi Akiba, Yoshindo Kawaguchi, James A. Sloand
Publikováno v:
Clinical and Experimental Nephrology
Background We report here two new peritoneal dialysis fluids (PDFs) for Japan [BLR 250, BLR 350 (Baxter Limited, Japan)]. The PDFs use two-chamber systems, and have bicarbonate and lactate buffer to a total of 35 mmol/L. In separate trials, the new P